Subthreshold Laser Treatment for Reticular Pseudodrusen and Geographic Atrophy Secondary to AMD

Inclusion Criteria: * GA \< 0.5 disk areas secondary to AMD and/or Reticular pseudodrusen * 50 years or older * The periphery of the atrophic lesions must demonstrate increased autofluorescence * Best corrected visual acuity between 20/20 and 20/400 inclusive * Clear ocular media * Ability to provide informed consent and attend all study visits Exclusion Criteria: * GA secondary to other causes aside from AMD * Evidence of choroidal neovascularization in either eye * Any prior treatment for AMD, aside from antioxidants * Any other ocular condition that would progress in the study period and confound visual acuity assessment * Any ocular or systemic medication known to be toxic to the lens, retina or optic nerve * Presence of idiopathic or autoimmune-associated uveitis * Any intraocular surgery 3 months of entry * Any prior thermal laser in the macula * History of vitrectomy, filtering surgery, corneal transplant or retinal detachment surgery * Previous therapeutic radiation in the ocular region in either eye * Any treatment with an investigational agent in the previous 60 days before study entry * Women of child-bearing potential, defined as all women less than 1 year postmenopausal or less than 6 weeks since sterilization at Baseline, unless they are using highly effective methods of contraception during dosing of study treatment * Participation in an investigational drug, biologic, or device study within 6 Months prior to Baseline \[Note: observational clinical studies solely involving over-the-counter vitamins, supplements, or diets are not exclusionary